Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Quality Control & Analytical Testing Services

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Nac Pharmaceuticals, operating under the Department of Veterans Affairs, is seeking a subcontractor to provide Quality Control and Analytical Testing Services. The scope of work focuses on comprehensive testing for both in-process and finished products, specifically covering assay, dissolution, impurity profiling, microbial limits, and stability studies. This subcontract falls under NAICS code 541380 and was posted on December 8, 2025. The agreement ensures that pharmaceutical products meet rigorous quality and safety standards through detailed analytical validation and ongoing stability monitoring.

General Info

NAICS

541380 - Testing Laboratories and Services

Place of Performance

IL

Set-Aside

NONE

Documents

This scope was carved out of 36E79725R0051.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

6505--Metformin SA Tablets

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
In-process and finished product testing including assay, dissolution, impurity profiling, microbial limits, and stability studies.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

6 days ago

DEADLINE

in 6 days
View Details
NAICS: 325412
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

12 days ago

DEADLINE

in 2 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS